Aegerion gets DOJ subpoena over marketing of cholesterol drug

(Reuters) – Aegerion Pharmaceuticals Inc said on Thursday that it received a subpoena from the U.S. Department of Justice, requesting documents related to the marketing and sale of its cholesterol…

    

Leave a Reply

Your email address will not be published.